FDA Approved: UPTRAVI — Original Application (Actelion Pharmaceuticals US, Inc.)

View source ↗

Summary

FDA approved UPTRAVI (selexipag) from Actelion Pharmaceuticals US, Inc. as the original approval for the treatment of pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Uptravi (selexipag)

Snippet

ORIG AP for UPTRAVI (SELEXIPAG)